Lane Deirdre A, Skjøth Flemming, Lip Gregory Y H, Larsen Torben B, Kotecha Dipak
University of Birmingham Institute of Cardiovascular Sciences, City Hospital, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, United Kingdom
Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
J Am Heart Assoc. 2017 Apr 28;6(5):e005155. doi: 10.1161/JAHA.116.005155.
Incidence and prevalence of atrial fibrillation (AF) are expected to increase dramatically; however, we currently lack comprehensive data on temporal trends in unselected clinical populations.
Analysis of the UK Clinical Practice Research Datalink (CPRD) from 1998 to 2010 of patients with incident AF, excluding major valvular disease, linked to hospital admission data and national statistics. Fifty-seven thousand eight hundred eighteen adults were identified with mean age 74.2 (SD, 11.7) years and 48.3% women. Overall age-adjusted incidence of AF per 1000 person years was 1.11 (95% CI, 1.09-1.13) in 1998-2001, 1.33 (1.31-1.34) in 2002-2006, and 1.33 (1.31-1.35) in 2007-2010. Ongoing increases in incidence were noted for patients aged ≥75 years, with similar temporal patterns in women and men. Associated comorbidities varied over time, with a constant prevalence of previous stroke, increases in hypertension and diabetes mellitus, and decreases in ischemic heart disease. Among patients aged 55 to 74 years, there was a significant reduction in mortality over time (<0.001), but mortality rates in patients aged ≥75 years remained static at 14% to 15% per year (=0.84). Projections of AF prevalence demonstrated a constant yearly rise, increasing from 700 000 patients in 2010 to between 1.3 and 1.8 million patients with AF in the United Kingdom by 2060.
In a large general practice population, incident AF increased and then plateaued overall, with a continued increase in patients aged ≥75 years. The large projected increase in AF prevalence associated with temporal changes in AF-related comorbidities suggests the need for comprehensive implementation of AF prevention and management strategies.
预计心房颤动(AF)的发病率和患病率将大幅上升;然而,我们目前缺乏关于未选择的临床人群时间趋势的全面数据。
对英国临床实践研究数据链(CPRD)1998年至2010年期间新发房颤患者(不包括严重瓣膜病)进行分析,并与医院入院数据和国家统计数据相关联。共识别出57818名成年人,平均年龄74.2(标准差11.7)岁,女性占48.3%。1998 - 2001年,年龄调整后的房颤总体发病率为每1000人年1.11(95%可信区间,1.09 - 1.13);2002 - 2006年为1.33(1.31 - 1.34);2007 - 2010年为1.33(1.31 - 1.35)。≥75岁患者的发病率持续上升,男性和女性的时间模式相似。相关合并症随时间变化,既往中风患病率恒定,高血压和糖尿病患病率上升,缺血性心脏病患病率下降。在55至74岁患者中,死亡率随时间显著降低(<0.001),但≥75岁患者的死亡率每年保持在14%至15%(P = 0.84)。房颤患病率预测显示每年持续上升,从2010年的70万患者增加到2060年英国130万至180万房颤患者。
在一个大型全科医疗人群中,新发房颤先增加后趋于平稳,≥75岁患者持续增加。预计房颤患病率大幅上升且与房颤相关合并症的时间变化有关,这表明需要全面实施房颤预防和管理策略。